Sequence-based deep learning antibody design for in silico antibody affinity maturation

• URL: http://arxiv.org/abs/2103.03724v1
• Date: Sun, 21 Feb 2021 02:48:31 GMT
• Title: Sequence-based deep learning antibody design for in silico antibody affinity maturation
• Authors: Yue Kang, Dawei Leng, Jinjiang Guo, Lurong Pan
• Abstract summary: optimization step for therapeutic leads is increasingly popular in antibody discovery pipeline. Traditional methods and in silico approaches aim to generate candidates with high binding affinity against specific target antigens. In the present study, we investigated different graph-based designs for depicting antibody-antigen interactions in terms of antibody affinity prediction.
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Antibody therapeutics has been extensively studied in drug discovery and development within the past decades. One increasingly popular focus in the antibody discovery pipeline is the optimization step for therapeutic leads. Both traditional methods and in silico approaches aim to generate candidates with high binding affinity against specific target antigens. Traditional in vitro approaches use hybridoma or phage display for candidate selection, and surface plasmon resonance (SPR) for evaluation, while in silico computational approaches aim to reduce the high cost and improve efficiency by incorporating mathematical algorithms and computational processing power in the design process. In the present study, we investigated different graph-based designs for depicting antibody-antigen interactions in terms of antibody affinity prediction using deep learning techniques. While other in silico computations require experimentally determined crystal structures, our study took interest in the capability of sequence-based models for in silico antibody maturation. Our preliminary studies achieved satisfying prediction accuracy on binding affinities comparing to conventional approaches and other deep learning approaches. To further study the antibody-antigen binding specificity, and to simulate the optimization process in real-world scenario, we introduced pairwise prediction strategy. We performed analysis based on both baseline and pairwise prediction results. The resulting prediction and efficiency prove the feasibility and computational efficiency of sequence-based method to be adapted as a scalable industry practice.

Related papers

• Evaluation Framework for AI-driven Molecular Design of Multi-target Drugs: Brain Diseases as a Case Study [0.0]
  Multi-target Drug Discovery (MTDD) is an emerging paradigm for discovering drugs against complex disorders. This work proposes an evaluation framework for molecule generation techniques in MTDD scenarios.
  arXiv  Detail & Related papers  (2024-08-20T01:42:16Z)
• Active learning for affinity prediction of antibodies [45.58662352490961]
  For large molecules such as antibodies, identifying mutations that enhance antibody affinity is challenging. FERB methods can offer valuable insights into how different mutations will impact the potency and selectivity of a drug candidate. We present an active learning framework that iteratively proposes sequences for simulators to evaluate, thereby accelerating the search for improved binders.
  arXiv  Detail & Related papers  (2024-06-11T13:42:49Z)
• The Pitfalls and Promise of Conformal Inference Under Adversarial Attacks [90.52808174102157]
  In safety-critical applications such as medical imaging and autonomous driving, it is imperative to maintain both high adversarial robustness to protect against potential adversarial attacks. A notable knowledge gap remains concerning the uncertainty inherent in adversarially trained models. This study investigates the uncertainty of deep learning models by examining the performance of conformal prediction (CP) in the context of standard adversarial attacks.
  arXiv  Detail & Related papers  (2024-05-14T18:05:19Z)
• Antigen-Specific Antibody Design via Direct Energy-based Preference Optimization [51.28231365213679]
  We tackle antigen-specific antibody sequence-structure co-design as an optimization problem towards specific preferences. We propose direct energy-based preference optimization to guide the generation of antibodies with both rational structures and considerable binding affinities to given antigens.
  arXiv  Detail & Related papers  (2024-03-25T09:41:49Z)
• AI driven B-cell Immunotherapy Design [0.0]
  The effectiveness of antigen neutralisation and elimination hinges upon the strength, sensitivity, and specificity of the paratope-epitope interaction. In recent years, artificial intelligence and machine learning methods have made significant strides, revolutionising the prediction of protein structures and their complexes. This review focuses on the progress of machine learning-based tools and their frameworks in the domain of B-cell immunotherapy design.
  arXiv  Detail & Related papers  (2023-09-03T09:14:10Z)
• Antibody Representation Learning for Drug Discovery [7.291511531280898]
  We present results on a novel SARS-CoV-2 antibody binding dataset and an additional benchmark dataset. We compare three classes of models: conventional statistical sequence models, supervised learning on each dataset independently, and fine-tuning an antibody specific pre-trained language model. Experimental results suggest that self-supervised pretraining of feature representation consistently offers significant improvement in over previous approaches.
  arXiv  Detail & Related papers  (2022-10-05T13:48:41Z)
• Model-Agnostic Meta-Attack: Towards Reliable Evaluation of Adversarial Robustness [53.094682754683255]
  We propose a Model-Agnostic Meta-Attack (MAMA) approach to discover stronger attack algorithms automatically. Our method learns the in adversarial attacks parameterized by a recurrent neural network. We develop a model-agnostic training algorithm to improve the ability of the learned when attacking unseen defenses.
  arXiv  Detail & Related papers  (2021-10-13T13:54:24Z)
• Bayesian prognostic covariate adjustment [59.75318183140857]
  Historical data about disease outcomes can be integrated into the analysis of clinical trials in many ways. We build on existing literature that uses prognostic scores from a predictive model to increase the efficiency of treatment effect estimates.
  arXiv  Detail & Related papers  (2020-12-24T05:19:03Z)
• Double Robust Representation Learning for Counterfactual Prediction [68.78210173955001]
  We propose a novel scalable method to learn double-robust representations for counterfactual predictions. We make robust and efficient counterfactual predictions for both individual and average treatment effects. The algorithm shows competitive performance with the state-of-the-art on real world and synthetic data.
  arXiv  Detail & Related papers  (2020-10-15T16:39:26Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.